NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Links shared publicly online about this topic.

1,388
total visits

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.

View full resource at news-medical.net

Tags: Cancer, Neutropenia Medication, Clinical Trial, Neupogen, Oncology, Transplantation